Occlusion Devices Market accounted for over ~US$ 2.9 billion in 2019. It is anticipated to grow at a CAGR of 5.2% from 2020 to 2030.
The growth of the occlusion devices market can be attributed to several factors, such as the preference for minimally invasive procedures, growing economies, well-established healthcare settings and the prevalence of cardiovascular and other chronic diseases. Moreover, rising awareness among people regarding disease treatments, increasing health expenditure and the effectiveness of occlusion devices in preventing strokes have further added to the demand for occlusion devices in the treatment of health conditions worldwide. Furthermore, the efficiency and availability of specific occlusion devices to treat urological, neurological, and gynecological conditions, among others, are anticipated to drive growth of the occlusion devices market.
Major Key Players of the Occlusion Devices Market are:
Abbott, Cardinal Health, Boston Scientific Corporation, Medtronic, Edwards Lifesciences Corporation, BD, ASAHI INTECC CO., LTD., BVM Medical Limited, Acrostak Int., Cook, and others.
No comments:
Post a Comment